1. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
- Author
-
Malvestutto C
- Subjects
- Humans, Risk Assessment, Risk Factors, Atherosclerosis drug therapy, Atherosclerosis epidemiology, Atherosclerosis etiology, Cardiovascular Diseases drug therapy, Cardiovascular Diseases epidemiology, Cardiovascular Diseases prevention & control, Dyslipidemias drug therapy, Dyslipidemias epidemiology, HIV Infections complications, HIV Infections drug therapy, HIV Infections epidemiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
- Abstract
Learning Objectives: Summarize the multiple atherosclerotic cardiovascular disease (ASCVD) risk factors commonly present in persons living with human immunodeficiency virus (HIV). Identify factors for clinical assessment and risk stratification in persons with HIV (PWH). Discuss the clinical challenges of dyslipidemia management among the HIV population, including avoidance of major drug-drug interactions (DDIs). Implement appropriate and safe statin therapy in PWH and elevated ASCVD risk.
- Published
- 2022
- Full Text
- View/download PDF